| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
author index
|
|
|
|
18 |
S4 |
p. iv53-iv55
|
article
|
| 2 |
committees
|
|
|
|
18 |
S4 |
p. iv8
|
article
|
| 3 |
MDICT Task Force: Methodology for the Development of Innovative Cancer Therapies
|
Eisenhauer, E.A.
|
|
|
18 |
S4 |
p. iv7
|
article
|
| 4 |
meeting schedule, FRIDAY, MARCH 9, 2007
|
|
|
|
18 |
S4 |
p. iv11-iv15
|
article
|
| 5 |
meeting schedule: OVERVIEW
|
|
|
|
18 |
S4 |
p. iv9
|
article
|
| 6 |
meeting schedule, SATURDAY, MARCH 10, 2007
|
|
|
|
18 |
S4 |
p. iv16
|
article
|
| 7 |
meeting schedule, THURSDAY, MARCH 8, 2007
|
|
|
|
18 |
S4 |
p. iv10
|
article
|
| 8 |
plenary session 3: angiogenesis inhibitors and vascular targeting agents
|
|
|
|
18 |
S4 |
p. iv20
|
article
|
| 9 |
plenary session 10: apoptosis as a drug target
|
|
|
|
18 |
S4 |
p. iv30
|
article
|
| 10 |
plenary session 6: immunotherapeutic approaches to cancer therapy
|
|
|
|
18 |
S4 |
p. iv24-iv25
|
article
|
| 11 |
plenary session 4: inhibitors of growth factor receptors and their tyrosine kinases
|
|
|
|
18 |
S4 |
p. iv21-iv22
|
article
|
| 12 |
plenary session 8: methodological and regulatory issues in oncology drug development
|
|
|
|
18 |
S4 |
p. iv28
|
article
|
| 13 |
plenary session 7: new drug targets
|
|
|
|
18 |
S4 |
p. iv26-iv27
|
article
|
| 14 |
plenary session 1: opening, keynotes and reviews
|
|
|
|
18 |
S4 |
p. iv17
|
article
|
| 15 |
plenary session 2: phase I & II studies of targeted agents
|
|
|
|
18 |
S4 |
p. iv18-iv19
|
article
|
| 16 |
plenary session 9: proffered papers and poster review
|
|
|
|
18 |
S4 |
p. iv29
|
article
|
| 17 |
plenary session 5: signal transduction modulators and mitosis inhibitors
|
|
|
|
18 |
S4 |
p. iv23
|
article
|
| 18 |
poster session 5: angiogenesis and tumor vasculature
|
|
|
|
18 |
S4 |
p. iv42-iv43
|
article
|
| 19 |
poster session 4: clinical studies
|
|
|
|
18 |
S4 |
p. iv39-iv41
|
article
|
| 20 |
poster session 7: molecular diagnosis, patient selection and prognosis
|
|
|
|
18 |
S4 |
p. iv47-iv50
|
article
|
| 21 |
poster session 1: new drug targets
|
|
|
|
18 |
S4 |
p. iv31-iv32
|
article
|
| 22 |
poster session 2: preclinical drug profiles
|
|
|
|
18 |
S4 |
p. iv33-iv37
|
article
|
| 23 |
poster session 3: prodrugs, conjugates and new formulations
|
|
|
|
18 |
S4 |
p. iv38
|
article
|
| 24 |
poster session 6: signalling pathways and apoptosis
|
|
|
|
18 |
S4 |
p. iv44-iv46
|
article
|
| 25 |
subject index
|
|
|
|
18 |
S4 |
p. iv51-iv52
|
article
|
| 26 |
Table of Contents
|
|
|
|
18 |
S4 |
p. ii
|
article
|
| 27 |
TAT 2007 sponsors & grants
|
|
|
|
18 |
S4 |
p. iv5
|
article
|
| 28 |
title page
|
Giaccone, G.
|
|
|
18 |
S4 |
p. iv1
|
article
|
| 29 |
welcome to TAT 2007!
|
|
|
|
18 |
S4 |
p. iv6
|
article
|
Journal description